Manojkumar Bupathi, MD, MS, discusses physician perspectives on treatment selection for frontline metastatic renal cell carcinoma (RCC) from a Case-Based Roundtable event.
Manojkumar Bupathi, MD, MS
Manojkumar Bupathi, MD, MS, is medical oncologist at Rocky Mountain Cancer Centers. He specializes in solid tumors with an advanced subspecialty expertise in breast cancers and genitourinary cancers
Articles by Manojkumar Bupathi, MD, MS
Manojkumar Bupathi, MD, MS, discusses the updated efficacy results of the CheckMate 9ER trial of cabozantinib plus nivolumab for patients with previously untreated advanced clear cell renal cell carcinoma.